Navigation Links
Lawsuit Alleges Takeda Pharmaceutical Co., Maker of Diabetes Drug Actos, Didn’t Warn of the Drug’s Risks Soon Enough; Parker Waichman LLP Responds
Date:9/6/2013

New York, NY (PRWEB) September 06, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, notes that, according to a Sept. 4 Bloomberg report, during a trial over the diabetes drug Actos, a lawyer for the Plaintiff alleged Takeda Pharmaceutical Co. had failed to warn consumers about certain cancer risks related to the drug (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland).

Takeda officials knew by 2005 that studies had shown links between Actos and cancer and didn’t issue a warning until six years later, the lawyer alleged in opening arguments, according to the Bloomberg report.

The U.S. Food and Drug Administration (FDA), which approved Actos, has been warning of the risks of the drug since 2011. On June 15, 2011, the agency said that taking Actos for more than a year could significantly increase the risk of bladder cancer. The safety label on Actos was updated to address this risk.

“The FDA was among the first to determine the drug Actos can cause an elevated risk in bladder cancer among those who take it for around a year,” said Parker Waichman LLP. “At least now we seem to be on the same page about the potential dangers associated with this drug.”

Aside from the FDA, research studies from other groups provide additional support for the notion of a link between Actos and bladder cancer. The British Medical Journal published a study on May 31, 2012, that revealed Actos users were twice as likely to develop bladder cancer after two years. Then, on July 3, 2012, the Canadian Medical Association Journal reported that patients taking the medication were 22 percent more likely to get bladder cancer.

Parker Waichman LLP continues to offer free legal consultations to victims of injuries allegedly caused by Actos, including bladder cancer, heart problems, and eye injuries. If you or a loved one were diagnosed with bladder cancer after taking Actos, please contact their office by visiting yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Contact:
Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+ (800) LAW-INFO
1+ (800) 529-4636

Read the full story at http://www.prweb.com/releases/Actos_trial_Bloomberg/09/prweb11098139.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Knee Sleeve Lawsuits Help: Resource4thePeople Expands Recall Reviews to include both Knee and Hip Cases
2. Biomet Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order and Stipulation in Federal Biomet Hip Replacement Litigation
3. DePuy Pinnacle Lawsuit News: Claims Filed in Federal DePuy Pinnacle Hip Litigation Approach 5,000, Bernstein Liebhard LLP Reports
4. Mirena IUD Lawsuit Help: Resource4thePeople Reports Number of Consolidated Cases Increases as Litigation Advances
5. C8 Lawsuit Lawyers at Wright & Schulte LLC Applaud Scheduling of First Trials in Multidistrict Litigation Established for Federal DuPont C8 Lawsuits
6. Actos Lawsuit News: Bernstein Liebhard LLP Notes Start of Second Actos Bladder Cancer Trial in Maryland State Court
7. Da Vinci Surgery Lawsuit News: Bernstein Liebhard LLP Comments on New Research that Suggests Robotic Surgery Complications Underreported
8. DrugRisk News: Court Consolidates Januvia Lawsuits Alleging Cancer
9. Transvaginal Mesh Lawsuits Help: Resource4thePeople Reports Key Trials Scheduled in Consolidated Federal Cases as Number of Cases Increases
10. Biomet Hip Lawsuits News: Judge Denies Biomet Motion to Dismiss Lawsuit, Reports Rottenstein Law Group LLP
11. NuvaRing Lawsuit Filed by Alonso Krangle Alleges That Use of NuvaRing Caused a Louisiana Woman to Develop a Life-Threatening Blood Clot Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, ... a medical article to the newly revamped Cosmetic Town journal section, ... hair transplant procedure known as Follicular Unit Extraction (FUE). , Dr. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
Breaking Medicine Technology: